http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104379166-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639cde93ad25c4794ecf02278c933fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59b6956351c0f0027a51862b03b51264
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
filingDate 2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007f05e9cbd5723df92d8188c45cf2be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7c76bb6ad257258830d1a2877649ca6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f18d38154398e7edafdb0a490460a25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26c6899540546ac950676e3954c1aef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72babf20529de332e6e17658fcf12bb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce47831e057fd72539f9e305e79045d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebf3a22944cd1dda729232cb35857cb4
publicationDate 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104379166-A
titleOfInvention Combination therapy involving antibodies against claudin 18.2 for the treatment of cancer
abstract The present invention provides a combination therapy for effective treatment and/or prevention of diseases associated with cells expressing CLDN18.2, including cancer diseases, such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer , liver cancer, head and neck cancer and gallbladder cancer and their metastasis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020200196-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113544156-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020135674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113788894-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109844125-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112888458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020063988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113788894-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113574171-A
priorityDate 2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010141093-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012020989-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146697397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406898322

Total number of triples: 55.